{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:19:39Z","timestamp":1752229179279},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,5,4]],"date-time":"2010-05-04T00:00:00Z","timestamp":1272931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11060-010-0207-8","type":"journal-article","created":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T11:04:42Z","timestamp":1272884682000},"page":"475-479","source":"Crossref","is-referenced-by-count":2,"title":["Tonsillar pseudotumor: complications of chronically-administered temozolomide"],"prefix":"10.1007","volume":"100","author":[{"given":"Kathleen","family":"Grisdale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melesa","family":"Ritterhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morris D.","family":"Groves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,4]]},"reference":[{"issue":"10","key":"207_CR1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"key":"207_CR2","volume-title":"Considering longer chemotherapy","author":"A Pollack","year":"2009","unstructured":"Pollack A (2009) Considering longer chemotherapy. The New York Times, New York"},{"issue":"5","key":"207_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME et al (2009) Effects of radiotherapy with concomitant with adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459\u2013466","journal-title":"Lancet Oncol"},{"issue":"8","key":"207_CR4","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1002\/cncr.23813","volume":"113","author":"JR Perry","year":"2008","unstructured":"Perry JR, Rizek P et al (2008) Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the \u201crescue\u201d approach. Cancer 113(8):2152\u20132157","journal-title":"Cancer"},{"issue":"9","key":"207_CR5","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1200\/JCO.1999.17.9.2762","volume":"17","author":"WK Yung","year":"1999","unstructured":"Yung WK, Prados MD et al (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 17(9):2762\u20132771","journal-title":"J Clin Oncol"},{"issue":"6","key":"207_CR6","first-page":"1120","volume":"10","author":"MM Mrugala","year":"2008","unstructured":"Mrugala MM, Johnston SK et al (2008) Cytopenias in patients with newly diagnosed high-grade gliomas receiving radiation and temozolomide-who is at risk? Neuro Oncol 10(6):1120 (abstract P156)","journal-title":"Neuro Oncol"},{"issue":"1","key":"207_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1215\/15228517-2006-024","volume":"9","author":"DE Gerber","year":"2007","unstructured":"Gerber DE, Grossman SA et al (2007) The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Neuro Oncol 9(1):47\u201352","journal-title":"Neuro Oncol"},{"issue":"4","key":"207_CR8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.2004.07.060","volume":"22","author":"YB Su","year":"2004","unstructured":"Su YB, Sohn S et al (2004) Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol 22(4):610\u2013616","journal-title":"J Clin Oncol"},{"issue":"5","key":"207_CR9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jinf.2008.06.021","volume":"57","author":"G Georgescu","year":"2008","unstructured":"Georgescu G, Isola IM et al (2008) Disseminated salmonellosis in a patient treated with temozolomide. J Infect 57(5):414\u2013415","journal-title":"J Infect"},{"issue":"9","key":"207_CR10","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/01.wnl.0000255937.27012.ee","volume":"68","author":"P Hau","year":"2007","unstructured":"Hau P, Koch D et al (2007) Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. Neurology 68(9):688\u2013690","journal-title":"Neurology"},{"issue":"1","key":"207_CR11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11060-009-9806-7","volume":"94","author":"E Binello","year":"2009","unstructured":"Binello E, Germano IM (2009) Tonsillary carcinoma after temozolomide treatment for glioblastoma multiforme: treatment-related or dual-pathology? J Neurooncol 94(1):145\u2013148","journal-title":"J Neurooncol"},{"issue":"3","key":"207_CR12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000029377","volume":"66","author":"M Tamm","year":"1999","unstructured":"Tamm M (1999) The lung in the immunocomprised patients. Infectious complications part 2. Respiration 66(3):199\u2013207","journal-title":"Respiration"},{"issue":"2","key":"207_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0924-8579(00)00233-8","volume":"16","author":"R Snoeck","year":"2000","unstructured":"Snoeck R (2000) Antiviral therapy of herpes simplex. Int J Antimicrob Agents 16(2):157\u2013159","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0207-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-010-0207-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0207-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:19:41Z","timestamp":1559348381000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-010-0207-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,4]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["207"],"URL":"https:\/\/doi.org\/10.1007\/s11060-010-0207-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,4]]}}}